Social Cognitive and Clinical Factors Associated with HPV Vaccine Initiation Among Urban, Economically Disadvantaged Women

JOGNN - Journal of Obstetric, Gynecologic, and Neonatal Nursing

Volumn 40, Issue 6, 2011, Pages 691-701

  Teitelman, Anne M ^a   Stringer, Marilyn ^a   Nguyen, Giang T ^a   Hanlon, Alexandra L ^a   Averbuch, Tali ^a   Stimpfel, Amy Witkoski ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adolescent; Cervical cancer; HPV vaccine; Prevention; Sexual health; Theory of planned behavior; Women's health

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ARTICLE; ATTITUDE TO HEALTH; CAUCASIAN; COGNITION; ETHNOLOGY; FEMALE; HISPANIC; HUMAN; INFORMATION PROCESSING; PAPILLOMAVIRUS INFECTION; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; RISK FACTOR; SEXUALITY; SOCIOECONOMICS; STATISTICS; UNITED STATES; URBAN POPULATION; UTERINE CERVIX TUMOR; VACCINATION; VIROLOGY; VULNERABLE POPULATION;

ADOLESCENT; ADULT; AFRICAN AMERICANS; COGNITION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOCUS GROUPS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HISPANIC AMERICANS; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; PHILADELPHIA; QUESTIONNAIRES; RISK FACTORS; SEXUAL PARTNERS; SOCIOECONOMIC FACTORS; URBAN POPULATION; UTERINE CERVICAL NEOPLASMS; VACCINATION; VULNERABLE POPULATIONS; YOUNG ADULT;

EID: 84861704088     PISSN: 08842175     EISSN: 15526909     Source Type: Journal    
DOI: 10.1111/j.1552-6909.2011.01297.x     Document Type: Article

References (49)

1. Ajzen, I. (1985). From intentions to actions: A theory of planned behavior. In J. Kuhl & J. Beckmann (Eds.), Action control: From cognition to behavior (pp. 11-39). Berlin, Germany: Springer-Verlag.
2. Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50, 179-211.
3. Akers, A. Y., Newmann, S. J., & Smith, J. S. (2007). Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Current Problems in Cancer, 31 (3), 157-181. doi:10.1016/j.currproblcancer.2007.01.001
4. Albarracin, D., Johnson, B. T., Fishbein, M., & Muellerleile, P. A. (2001). Theories of reasoned action and planned behavior as models of condom use: A meta-analysis. Psychological Bulletin, 127 (1), 142-161.
5. Allen, J. D., Coronado, G. D., Williams, R. S., Glenn, B., Escoffery, C., Fernandez, M., Mullen, P. D. (2010). A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine, 28 (24), 4027-4037. doi:10.1016/j.vaccine.2010.03.063
6. Armitage, C. J., & Conner, M. (2001). Efficacy of the theory of planned behaviour: A meta-analytic review. British Journal of Social Psychology / the British Psychological Society, 40 (Pt 4), 471-499.
7. Bertram, C., & Niederhuaser, V. P. (2008). Uncertain knowledge of a certain virus: Human papillomavirus and abnormal pap smears: An Internet survey of knowledge and beliefs among a university population in Hawaii. American Journal of Health Education, 39 (1), 15-24.
8. Bosch, F. X., & de Sanjose, S. (2007). The epidemiology of human papillomavirus infection and cervical cancer. Disease Markers, 23 (4), 213-227.
9. Cates, J. R., Brewer, N. T., Fazekas, K. I., Mitchell, C. E., & Smith, J. S. (2009). Racial differences in HPV knowledge, HPV vaccine acceptability, and related beliefs among rural, southern women. Journal of Rural Health, 25 (1), 93-97. doi:10.1111/j.1748-0361.2009.00204.x
10. Centers for Disease Control and Prevention. (n.d.). What parents of preteens/adolescents should know about the HPV vaccine. Atlanta, GA. Retrieved from
11. Centers for Disease Control and Prevention. (2008). Surveillance for cancers associated with tobacco use - United States, 1999-2004. MMWR Morbidity and Mortality Weekly Report, 57, SS-8.
12. Centers for Disease Control and Prevention. (2010a). FDA licensure of bivalent human papillomavirus vaccine (HPV2, cervarix) for use in females and updated HPV vaccine recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morbidity and Mortality Weekly Report, 59 (20), 626-629.
13. Centers for Disease Control and Prevention. (2010b). National, state, and local area vaccine coverage among adolescents aged 13-17 years - United States, 2009. MMWR Morbidity and Mortality Weekly Report, 59 (32), 1018-1023.
14. Chan, S. S., Cheung, T. H., Lo, W. K., & Chung, T. K. (2007). Women's attitudes on human papillomavirus vaccine to their daughters. Journal of Adolescent Health, 41 (2), 204-207. doi:10.1016/j.jadohealth.2007.04.011
15. Conroy, K., Rosenthal, S. L., Zimet, G. D., Jin, Y., Bernstein, D. I., Glynn, S., & Kahn, J. A. (2009). Human papillomavirus vaccine uptake, predictors of vaccine, and self-reported barriers to vaccine. Journal of Women's Health, 18 (10), 1679-1686. doi:10.1089/jwh.2008.1329
16. Constantine, N. A., & Jerman, P. (2007). Acceptance of human papillomavirus vaccine among Californian parents of daughters: A representative statewide analysis. Journal of Adolescent Health, 40 (2), 108-115. doi:10.1016/j.jadohealth.2006.10.007
17. Crosby, R., Schoenberg, N., Hopenhayn, C., Moore, G., & Melhan, W. (2007). Correlates of intent to be vaccinated against human papillomavirus: An exploratory study of college-aged women. Sexual Health, 4 (1), 71--73.
18. Cunningham, W. E., Hays, R. D., Duan, N., Andersen, R., Nakazono, T. T., Bozzette, S. A., & Shapiro, M. F. (2005). The effect of socioeconomic status on the survival of people receiving care for HIV infection in the United States. Journal of Health Care for the Poor and Underserved, 16 (4), 655-676. doi:10.1353/hpu.2005.0093
19. de Visser, R., & McDonnell, E. (2008). Correlates of parents' reports of acceptability of human papillomavirus vaccine for their school-aged children. Sexual Health, 5 (4), 331-338.
20. Dempsey, A., Cohn, L., Dalton, V., & Ruffin, M. (2011). Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine, 29 (3), 528-534. doi:10.1016/j.vaccine.2010.10.051
21. Dempsey, A. F., Zimet, G. D., Davis, R. L., & Koutsky, L. (2006). Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics, 117 (5), 1486-1493. doi:10.1542/peds.2005-1381
22. Doty, M., & Holmgren, A. (2004). Unequal access: Insurance instability among low-income workers and minorities (No. 729). New York, NY: The Commonwealth Fund. Retrieved from
23. Dursun, P., Altuntas, B., Kuscu, E., & Ayhan, A. (2009). Women's knowledge about human papillomavirus and their acceptance of HPV vaccine. Australian & New Zealand Journal of Obstetrics & Gynaecology, 49 (2), 202-206. doi:10.1111/j.1479-828X.2009.00947.x
24. Fazekas, K. I., Brewer, N. T., & Smith, J. S. (2008). HPV vaccine acceptability in a rural southern area. Journal of Women's Health, 17 (4), 539-548. doi:10.1089/jwh.2007.0489
25. Fichtenberg, C. M., Jennings, J. M., Glass, T. A., & Ellen, J. M. (2010). Neighborhood socioeconomic environment and sexual network position. Journal of Urban Health, 87 (2), 225-235. doi:10.1007/s11524-009-9425-9
26. Fishbein, M., & Ajzen, I. (1975). Belief, attitude, intention, and behavior: An introduction to theory and research. Reading, MA: Addison-Wesley.
27. Forhan, S. E., Gottlieb, S. L., Sternberg, M. R., Xu, F., Datta, S. D., McQuillan, G. M., & Markowitz, L. E. (2009). Prevalence of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics, 124 (6), 1505-1512. doi:10.1542/peds.2009-0674
28. Gerend, M. A., & Barley, J. (2009). Human papillomavirus vaccine acceptability among young adult men. Sexually Transmitted Diseases, 36 (1), 58-62 doi:10.1097/OLQ.0b013e31818606fc
29. Gerend, M. A., Lee, S. C., & Shepherd, J. E. (2007). Predictors of human papillomavirus vaccine acceptability among underserved women. Sexually Transmitted Diseases, 34 (7), 468-471. doi:10.1097/01.olq.0000245915.38315.bd
30. Gerend, M. A., & Magloire, Z. F. (2008). Awareness, knowledge, and beliefs about human papillomavirus in a racially diverse sample of young adults. Journal of Adolescent Health, 42 (3), 237-242. doi:10.1016/j.jadohealth.2007.08.022
31. Haggar, M. S., Chatzisarantis, N., & Biddle, S. J. H. (2002). A meta-analytic view of the theories of reasoned action and planned behavior in physical activity: Predictive validity and the contribution of additional variables. Journal of Sport and Exercise Physiology, 24 (3), 3-32.
32. Jessor, R. (1998). New perspectives on adolescent risk behavior. New York, NY: Cambridge University Press.
33. Jessor, R. (1991). Risk behavior in adolescence: A psychosocial framework for understanding and action. Journal of Adolescent Health, 12 (8), 597-605.
34. Kahn, J. A., Ding, L., Huang, B., Zimet, G. D., Rosenthal, S. L., & Frazier, A. L. (2009). Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: A national study of nurses. Pediatrics, 123 (6), 1439-1445. doi:10.1542/peds.2008-1536.
35. Kahn, J. A., Lan, D., & Kahn, R. S. (2007). Sociodemographic factors associated with high-risk human papillomavirus infection. Obstetrics & Gynecology, 110 (1), 87-95. doi:10.1097/01.AOG.0000266984.23445.9c
36. Katz, M. L., Reiter, P. L., Heaner, S., Ruffin, M. T., Post, D. M., & Paskett, E. D. (2009). Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine, 27 (30), 3945-3952. doi:10.1016/j.vaccine.2009.04.040
37. Keelan, J., Pavri, V., Balakrishnan, R., & Wilson, K. (2010). An analysis of the human papilloma virus vaccine debate on MySpace blogs. Vaccine, 28 (6), 1535-1540. doi:10.1016/j.vaccine.2009.11.060
38. Kerlinger, F., & Lee, H. (1999). Foundations of behavioral research (4th ed.). Fort Worth, TX: Harcourt College.
39. Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Newbury Park, CA: Sage.
40. Madden, T. J., Ellen, P. S., & Ajzen, I. (1992). A comparison of the theory of planned behavior and the theory of reasoned action. Personality and Social Psychology Bulletin, 18, 3-9.
41. Markowitz, L. E., Dunne, E. F., Saraiya, M., Lawson, H. W., Chesson, H., Unger, E. R., & Advisory Committee on Immunization Practices (ACIP). (2007). Quadrivalent human papillomavirus vaccine: Recommendations of the advisory committee on immunization practices (ACIP). MMWR Morbidity and Mortality Weekly Report, 56 (RR-2), 1-24.
42. Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook. Thousand Oaks, CA: Sage.
43. Millen, J. C., Ginde, A. A., Anderson, A. T., Fang, P., & Camargo, C. A., Jr. (2009). Multicenter study of knowledge about human papilloma virus and attitudes among emergency department patients. Journal of Pediatric and Adolescent Gynecology, 22 (6), 356-359. doi:10.1016/j.jpag.2009.03.001
44. National Cancer Institute. (2010). Cervical cancer. Bethesda, MD: National Institutes of Health. Retrieved from
45. Newmann, S. J., & Garner, E. O. (2005). Social inequities along the cervical cancer continuum: A structured review. Cancer Causes & Control, 16 (1), 63-70. doi:10.1007/s10552-004-1290-y
46. Read, D. S., Joseph, M. A., Polishchuk, V., & Suss, A. L. (2010). Attitudes and perceptions of the HPV vaccine in Caribbean and African-American adolescent girls and their parents. Journal of Pediatric & Adolescent Gynecology, 23 (4), 242-245. doi:10.1016/j.jpag.2010.02.002
47. U.S. Department of Health and Human Services. (2010). United States cancer statistics (USCS) 2007 cancer types grouped by race and ethnicity. Atlanta, GA: CDC. Retrieved from
48. U.S. Department of Health and Human Services. (1994). Preventing tobacco use among young people: A report of the surgeon general. MMWR Morbidity and Mortality Weekly Report, 43, RR-4.
49. Watts, L. A., Joseph, N., Wallace, M., Rauh-Hain, J. A., Muzikansky, A., Growdon, W. B., & del Carmen, M. G. (2009). HPV vaccine: A comparison of attitudes and behavioral perspectives between Latino and non-Latino women. Gynecologic Oncology, 112 (3), 577-582.